Saturday, May 23, 2026 | 07:40 AM ISTहिंदी में पढें
Jubilant Pharmova Ltd
Board Meeting Intimation for 1. The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31 2025.2. Recommendation Of Final Dividend If Any For The Financial Year Ended March 31 2025.
06:41 PM, 30th Apr 2025
Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 inter alia to consider and approve 1. The audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2025.2. Recommendation of Final Dividend if any for the Financial Year ended March 31 2025.